Parenteral Nutrition Market Report 2026

The parenteral nutrition market size has grown strongly in recent years. It will grow from $7.09 billion in 2025 to $7.52 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to growing incidence of malnutrition, rising hospital admissions, lack of awareness about parenteral nutrition, limited homecare adoption, increasing demand for critical care nutrition.

The parenteral nutrition market size is expected to see strong growth in the next few years. It will grow to $9.49 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to rising geriatric population, expansion of home healthcare services, innovations in nutrient formulations, government support for nutrition programs, integration of digital monitoring in PN therapy. Major trends in the forecast period include advanced nutrient formulations, home parenteral nutrition expansion, personalized nutrition therapy, minimally invasive administration devices, regulatory compliance & safety enhancements.

The increasing birth rate is expected to drive growth in the parenteral nutrition market. The birth rate refers to the number of live births per 1,000 people in a population each year. Rising birth and fertility rates are an important indicator of potential malnutrition risks among women of childbearing age and new mothers, thereby increasing the demand for parenteral nutrition. For instance, in July 2025, according to the Office for National Statistics Census, a UK-based government agency, England and Wales recorded 594,677 live births in 2024, an increase of 3,605 births (0.6%) compared with 591,072 live births in 2023. Therefore, the rising birth rate is fueling the growth of the parenteral nutrition market.

Major companies in the parenteral nutrition market are developing innovative formulations, such as high-calorie amino acid, glucose, electrolyte, fat, and multivitamin injections, to enhance nutritional support for patients with chronic conditions. These intravenous formulations provide complete macronutrient and micronutrient support for patients unable to meet their nutritional needs orally or enterally. For instance, in November 2024, Otsuka Pharmaceutical Factory, a Japan-based pharmaceutical company, launched KIDPAREN Injection, designed for high-calorie parenteral nutrition in patients with chronic kidney disease. This formulation aims to optimize patient care by delivering comprehensive nutrient support, ensuring adequate energy intake, and supporting metabolic requirements in chronic kidney disease management.

In July 2024, Access Infusion Care Inc., a US-based home infusion services provider, acquired Big Sky I.V. Care for an undisclosed amount. Through this acquisition, Access Infusion seeks to expand its geographic reach, strengthen service capabilities, improve patient access to infusion therapies, and enhance its competitive position in the US home infusion market. Big Sky I.V. Care is a US-based home infusion provider specializing in parenteral nutrition.

Major companies operating in the parenteral nutrition market are Fresenius Kabi, Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Otsuka Pharmaceutical Co Ltd, Claris Lifesciences Limited, Sichuan Kelun Pharmaceutical Co Ltd, JW Pharmaceuticals, Aculife Healthcare Pvt Ltd, Aspen Pharmacare, Ajinomoto Co Inc, Braun Medical Inc, Laboratoires Aguettant, AnazaoHealth Corporation, Baxter Healthcare Corporation, Sichuan Pharmaceutical Co, Calea UK, Meiji Holdings Co Ltd, United Pharmaceuticals, BioScrip Inc.

North America was the largest region in the parenteral nutrition market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the parenteral nutrition market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the parenteral nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the parenteral nutrition market by increasing the cost of imported nutrient components, medical devices, and specialized infusion equipment. This has particularly affected hospitals and homecare segments in regions such as North America and Europe, which rely heavily on imported high-quality formulations. While tariffs have raised operational costs and slowed supply chains, they have also encouraged local manufacturing and the development of cost-optimized nutrient solutions, fostering innovation and supply diversification in the market.

The parenteral nutrition market research report is one of a series of new reports that provides parenteral nutrition market statistics, including parenteral nutrition industry global market size, regional shares, competitors with a parenteral nutrition market share, detailed parenteral nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the parenteral nutrition industry. This parenteral nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Parenteral nutrition refers to the administration of nutrients directly into a vein (intravenously) as a medical treatment. The therapy aims to prevent or correct malnutrition. Delivering balanced nutrition in a timely manner helps reduce complications and plays a critical role in patient recovery.

The main components of parenteral nutrition include amino acids, fats, carbohydrates, trace elements, vitamins, minerals, and other nutrients. Amino acid-based parenteral nutrition consists of products derived from amino acids, which are essential in complete parenteral nutrition formulations to support cellular function, organ health, skeletal and respiratory muscle performance, and wound healing. These products are used for adults, children, and newborns across hospitals, clinics, homecare settings, and other healthcare environments.

The parenteral nutrition market includes revenues earned by entities by infusing a specialized form of food through a vein. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.